Analysis of serine codon conservation reveals diverse phenotypic constraints on hepatitis C virus glycoprotein evolution

Journal of Virology

Volumn 88, Issue 1, 2014, Pages 667-678

  Brown, Richard J P ^a   Koutsoudakisu, George ^b   Urbanowicz, Richard A ^c   Mirza, Deeman ^c   Ginkel, Corinne ^a   Riebesehl, Nina ^a   Calland, Noémie ^d   Albecka, Anna ^d   Price, Louisa ^c   Hudson, Natalia ^c   Descamps, Véronique ^e   Backx, Matthijs ^c   Patrick McClure, C ^c   Duverlie, Gilles ^e   Pecheur, Eve Isabelle ^f   Dubuisson, Jean ^d   Perez del Pulgar, Sofia ^g   Forns, Xavier ^g   Steinmann, Eike ^a   Tarr, Alexander W ^c   Pietschmann, Thomas ^a   Ball, Jonathan K ^c   more..

^a INSTITUTE OF INFECTION IMMUNOLOGY   (Germany)

^b UNIVERSITAT POMPEU FABRA   (Spain)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^d UNIV LILLE   (France)

^e AMIENS UNIVERSITY HOSPITAL   (France)

^f CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON   (France)

^g INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN E1; GLYCOPROTEIN E2; SERINE; THREONINE; VIRUS GLYCOPROTEIN;

AMINO ACID SUBSTITUTION; ARTICLE; CODON; DIMERIZATION; GENE SWITCHING; GENETIC CONSERVATION; GENOTYPE; HEPATITIS C VIRUS; NONHUMAN; PHENOTYPIC VARIATION; PHYLOGENY; PRIORITY JOURNAL; REVERSE GENETICS; SEQUENCE ALIGNMENT; VIRION; VIRUS INFECTIVITY; VIRUS NEUTRALIZATION; VIRUS PARTICLE; VIRUS STRAIN; VIRUS TITRATION;

CODON; EVOLUTION, MOLECULAR; GLYCOPROTEINS; HEPACIVIRUS; PHENOTYPE; PHYLOGENY; SERINE;

EID: 84890870335     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01745-13     Document Type: Article

References (52)

1. Shepard CW, Finelli L, Alter MJ. 2005. Global epidemiology of hepatitis C virus infection. Lancet Infect. Dis. 5:558-567. http://dx.doi.org/10.1016 /S1473-3099(05)70216-4.
2. Hoofnagle JH. 2002. Course and outcome of hepatitis C. Hepatology 36:S21-S29. http://dx.doi.org/10.1053/jhep.2002.36227.
3. Simmonds P. 2004. Genetic diversity and evolution of hepatitis C virus-15 years on. J. Gen. Virol. 85:3173-3188. http://dx.doi.org/10.1099 /vir.0.80401-0.
4. Lindenbach BD, Rice CM. 2005. Unravelling hepatitis C virus replication from genome to function. Nature 436:933-938. http://dx.doi.org/10.1038 /nature04077.
5. Neumann AU, Lam NP, Dahari H, Gretch DR, Wiley TE, Layden TJ, Perelson AS. 1998. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science 282:103-107. http://dx.doi .org/10.1126/science.282.5386.103.
6. Martell M, Esteban JI, Quer J, Genesca J, Weiner A, Esteban R, Guardia J, Gomez J. 1992. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature ofHCVgenome distribution. J. Virol. 66:3225-3229.
7. Bukh J, Miller RH, Purcell RH. 1995. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin. Liver Dis. 15:41-63. http://dx .doi.org/10.1055/s-2007-1007262.
8. Brown RJ, Tarr AW, McClure CP, Juttla VS, Tagiuri N, Irving WL, Ball JK. 2007. Cross-genotype characterization of genetic diversity and molecular adaptation in hepatitis C virus envelope glycoprotein genes. J. Gen. Virol. 88:458-469. http://dx.doi.org/10.1099/vir.0.82357-0.
9. Brown RJP, Juttla VS, Tarr AW, Finnis R, Irving WL, Hemsley S, Flower DR, Borrow P, Ball JK. 2005. Evolutionary dynamics of hepatitis C virus envelope genes during chronic infection. J. Gen. Virol. 86:1931-1942. http://dx.doi.org/10.1099/vir.0.80957-0.
10. Ray SC, Wang YM, Laeyendecker O, Ticehurst JR, Villano SA, Thomas DL. 1999. Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: hypervariable region 1 as a decoy. J. Virol. 73:2938-2946.
11. Sheridan I, Pybus OG, Holmes EC, Klenerman P. 2004. High-resolution phylogenetic analysis of hepatitisCvirus adaptation and its relationship to disease progression. J. Virol. 78:3447-3454. http://dx.doi.org/10.1128/JVI .78.7.3447-3454.2004.
12. von Hahn T, Yoon JC, Alter H, Rice CM, Rehermann B, Balfe P, McKeating JA. 2007. Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo. Gastroenterology 132:667-678. http://dx.doi.org/10.1053/j.gastro.2006 .12.008.
13. Logvinoff C, Major ME, Oldach D, Heyward S, Talal A, Balfe P, Feinstone SM, Alter H, Rice CM, McKeating JA. 2004. Neutralizing antibody response during acute and chronic hepatitis C virus infection. Proc. Nat. Acad. Sci. U. S. A. 101:10149-10154. http://dx.doi.org/10.1073 /pnas.0403519101.
14. Fafi-Kremer S, Fofana I, Soulier E, Carolla P, Meuleman P, Leroux-Roels G, Patel AH, Cosset FL, Pessaux P, Doffoel M, Wolf P, Stoll-Keller F, Baumert TF. 2010. Viral entry and escape from antibodymediated neutralization influence hepatitis C virus reinfection in liver transplantation. J. Exp. Med. 207:2019-2031. http://dx.doi.org/10.1084 /jem.20090766.
15. Albecka A, Montserret R, Krey T, Tarr AW, Diesis E, Ball JK, Descamps V, Duverlie G, Rey F, Penin F, Dubuisson J. 2011. Identification of new functional regions in hepatitis C virus envelope glycoprotein E2. J. Virol. 85:1777-1792. http://dx.doi.org/10.1128/JVI.02170-10.
16. Pietschmann T, Kaul A, Koutsoudakis G, Shavinskaya A, Kallis S, Steinmann E, Abid K, Negro F, Dreux M, Cosset FL, Bartenschlager R. 2006. Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. Proc. Nat. Acad. Sci. U. S. A. 103:7408-7413. http://dx.doi.org/10.1073/pnas.0504877103.
17. Steinmann E, Penin F, Kallis S, Patel AH, Bartenschlager R, Pietschmann T. 2007. Hepatitis C virus p7 protein is crucial for assembly and release of infectious virions. PLoS Pathog. 3:e103. http://dx.doi.org/10 .1371/journal.ppat.0030103.
18. Helle F, Vieyres G, Elkrief L, Popescu CI, Wychowski C, Descamps V, Castelain S, Roingeard P, Duverlie G, Dubuisson J. 2010. Role of N-linked glycans in the functions of hepatitis C virus envelope proteins incorporated into infectious virions. J. Virol. 84:11905-11915. http://dx .doi.org/10.1128/JVI.01548-10.
19. Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R, Weiner AJ, Houghton M, Rosa D, Grandi G, Abrignani S. 1998. Binding of hepatitis C virus to CD81. Science 282:938-941. http://dx.doi.org/10 .1126/science.282.5390.938.
20. Scarselli E, Ansuini H, Cerino R, Roccasecca RM, Acali S, Filocamo G, Traboni C, Nicosia A, Cortese R, Vitelli A. 2002. The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J. 21:5017-5025. http://dx.doi.org/10.1093/emboj/cdf529.
21. Evans MJ, von Hahn T, Tscherne DM, Syder AJ, Panis M, Wolk B, Hatziioannou T, McKeating JA, Bieniasz PD, Rice CM. 2007. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 446:801-805. http://dx.doi.org/10.1038/nature05654.
22. Ploss A, Evans MJ, Gaysinskaya VA, Panis M, You H, de Jong YP, Rice CM. 2009. Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature 457:882-886. http://dx.doi.org/10.1038 /nature07684.
23. Haid S, Pietschmann T, Pecheur EI. 2009. Low pH-dependent hepatitis C virus membrane fusion depends on E2 integrity, target lipid composition, and density of virus particles. J. Biol. Chem. 284:17657-17667. http: //dx.doi.org/10.1074/jbc.M109.014647.
24. Lavillette D, Bartosch B, Nourrisson D, Verney G, Cosset FL, Penin F, Pecheur EI. 2006. Hepatitis C virus glycoproteins mediate low pHdependent membrane fusion with liposomes. J. Biol. Chem. 281:3909-3917. http://dx.doi.org/10.1074/jbc.M509747200.
25. Averof M, Rokas A, Wolfe KH, Sharp PM. 2000. Evidence for a high frequency of simultaneous double-nucleotide substitutions. Science 287: 1283-1286. http://dx.doi.org/10.1126/science.287.5456.1283.
26. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. 2011. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 28:2731-2739. http://dx.doi.org/10.1093/molbev/msr121.
27. Guindon S, Dufayard JF, Lefort V, Anisimova M, Hordijk W, Gascuel O. 2010. New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst. Biol. 59:307-321. http://dx.doi.org/10.1093/sysbio/syq010.
28. Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, Zhao Z, Murthy K, Habermann A, Krausslich HG, Mizokami M, Bartenschlager R, Liang TJ. 2005. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11:791-796. http://dx.doi .org/10.1038/nm1268.
29. Bartosch B, Dubuisson J, Cosset FL. 2003. Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J. Exp. Med. 197:633-642. http://dx.doi.org/10.1084/jem .20021756.
30. Flint M, Maidens C, Loomis-Price LD, Shotton C, Dubuisson J, Monk P, Higginbottom A, Levy S, McKeating JA. 1999. Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81. J. Virol. 73:6235-6244.
31. Lindenbach BD, Evans MJ, Syder AJ, Wolk B, Tellinghuisen TL, Liu CC, Maruyama T, Hynes RO, Burton DR, McKeating JA, Rice CM. 2005. Complete replication of hepatitis C virus in cell culture. Science 309:623-626. http://dx.doi.org/10.1126/science.1114016.
32. Reed LJ, Muench H. 1938. A simple method of estimating fifty per cent endpoints. Am. J. Hyg. 24:493-497.
33. Goffard A, Callens N, Bartosch B, Wychowski C, Cosset FL, Montpellier C, Dubuisson J. 2005. Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins. J. Virol. 79:8400-8409. http://dx .doi.org/10.1128/JVI.79.13.8400-8409.2005.
34. Helle F, Goffard A, Morel V, Duverlie G, McKeating J, Keck Z-Y, Foung S, Penin F, Dubuisson J, Voisset C. 2007. The neutralizing activity of anti-hepatitisCvirus antibodies is modulated by specific glycans on the E2 envelope protein. J. Virol. 81:8101-8111. http://dx.doi.org/10.1128/JVI .00127-07.
35. Johansson DX, Voisset C, Tarr AW, Aung M, Ball JK, Dubuisson J, Persson MAA. 2007. Human combinatorial libraries yield rare antibodies that broadly neutralize hepatitis C virus. Proc. Nat. Acad. Sci. U. S. A. 104:16269-16274. http://dx.doi.org/10.1073/pnas.0705522104.
36. Wahid A, Helle F, Descamps V, Duverlie G, Penin F, Dubuisson J. 2013. Disulfide bonds in hepatitis C virus glycoprotein E1 control the assembly and entry functions of E2 glycoprotein. J. Virol. 87:1605-1617. http://dx.doi.org/10.1128/JVI.02659-12.
37. Brown RJ, Hudson N, Wilson G, Rehman SU, Jabbari S, Hu K, Tarr AW, Borrow P, Joyce M, Lewis J, Zhu LF, Law M, Kneteman N, Tyrrell DL, McKeating JA, Ball JK. 2012. Hepatitis C virus envelope glycoprotein fitness defines virus population composition following transmission to a new host. J. Virol. 86:11956-11966. http://dx.doi.org/10.1128/JVI.01079-12.
38. Giang E, Dorner M, Prentoe JC, Dreux M, Evans MJ, Bukh J, Rice CM, Ploss A, Burton DR, Law M. 2012. Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus. Proc. Nat. Acad. Sci. U. S. A. 109:6205-6210. http://dx.doi.org/10.1073/pnas .1114927109.
39. Keck ZY, Xia J, Wang Y, Wang W, Krey T, Prentoe J, Carlsen T, Li AY, Patel AH, Lemon SM, Bukh J, Rey FA, Foung SK. 2012. Human monoclonal antibodies to a novel cluster of conformational epitopes on HCV E2 with resistance to neutralization escape in a genotype 2a isolate. PLoS Pathog. 8:e1002653. http://dx.doi.org/10.1371/journal.ppat .1002653.
40. Law M, Maruyama T, Lewis J, Giang E, Tarr AW, Stamataki Z, Gastaminza P, Chisari FV, Jones IM, Fox RI, Ball JK, McKeating JA, Kneteman NM, Burton DR. 2008. Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge. Nat. Med. 14:25-27. http: //dx.doi.org/10.1038/nm1698.
41. Dorner M, Horwitz JA, Robbins JB, Barry WT, Feng Q, Mu K, Jones CT, Schoggins JW, Catanese MT, Burton DR, Law M, Rice CM, Ploss A. 2011. A genetically humanized mouse model for hepatitis C virus infection. Nature 474:208-211. http://dx.doi.org/10.1038/nature10168.
42. Bankwitz D, Steinmann E, Bitzegeio J, Ciesek S, Friesland M, Herrmann E, Zeisel MB, Baumert TF, Keck ZY, Foung SK, Pecheur EI, Pietschmann T. 2010. Hepatitis C virus hypervariable region 1 modulates receptor interactions, conceals the CD81 binding site, and protects conserved neutralizing epitopes. J. Virol. 84:5751-5763. http://dx.doi.org/10 .1128/JVI.02200-09.
43. Van Valen L. 1973. A new evolutionary law. Evol. Theory 1:1-30.
44. Krey T, d'Alayer J, Kikuti CM, Saulnier A, Damier-Piolle L, Petitpas I, Johansson DX, Tawar RG, Baron B, Robert B, England P, Persson MA, Martin A, Rey FA. 2010. The disulfide bonds in glycoprotein E2 of hepatitisCvirus reveal the tertiary organization of the molecule. PLoS Pathog. 6:e1000762. http://dx.doi.org/10.1371/journal.ppat.1000762.
45. Cocquerel L, Wychowski C, Minner F, Penin F, Dubuisson J. 2000. Charged residues in the transmembrane domains of hepatitis C virus glycoproteins play a major role in the processing, subcellular localization, and assembly of these envelope proteins. J. Virol. 74:3623-3633. http://dx .doi.org/10.1128/JVI.74.8.3623-3633.2000.
46. Sanjuan R. 2010. Mutational fitness effects in RNA and single-stranded DNA viruses: common patterns revealed by site-directed mutagenesis studies. Philos. Trans. R. Soc. Lond. B Biol. Sci. 365:1975-1982. http://dx .doi.org/10.1098/rstb.2010.0063.
47. Sanjuan R, Moya A, Elena SF. 2004. The distribution of fitness effects caused by single-nucleotide substitutions in an RNA virus. Proc. Nat. Acad. Sci. U. S. A. 101:8396-8401. http://dx.doi.org/10.1073/pnas .0400146101.
48. Bartenschlager R, Lohmann V, Penin F. 2013. The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection. Nat. Rev. Microbiol. 11:482-496. http://dx.doi.org/10.1038/nrmicro3046.
49. Dutartre H, Bussetta C, Boretto J, Canard B. 2006. General catalytic deficiency of hepatitis C virus RNA polymerase with an S282T mutation and mutually exclusive resistance towards 2=-modified nucleotide analogues. Antimicrob. Agents Chemother. 50:4161-4169. http://dx.doi.org /10.1128/AAC.00433-06.
50. Davis M, Sagan SM, Pezacki JP, Evans DJ, Simmonds P. 2008. Bioinformatic and physical characterizations of genome-scale ordered RNA structure in mammalian RNA viruses. J. Virol. 82:11824-11836. http://dx .doi.org/10.1128/JVI.01078-08.
51. Simmonds P, Tuplin A, Evans DJ. 2004. Detection of genome-scale ordered RNA structure (GORS) in genomes of positive-stranded RNA viruses: Implications for virus evolution and host persistence. RNA 10: 1337-1351. http://dx.doi.org/10.1261/rna.7640104.
52. Watts JM, Dang KK, Gorelick RJ, Leonard CW, Bess JW, Jr, Swanstrom R, Burch CL, Weeks KM. 2009. Architecture and secondary structure of an entire HIV-1 RNA genome. Nature 460:711-716. http://dx.doi.org/10 .1038/nature08237.